AUGUST 3, 2023, NEW YORK - A Ludwig Cancer Research study has identified a pair of genes whose expression by a type of immune cell within tumors is predictive of outcomes for cancer patients and is linked to a vast network of gene expression programs, engaged by multiple cell types in the tumor microenvironment, that control human cancers. Researchers led by Ludwig Lausanne's Mikaël Pittet report in the current issue of Science that patients with higher expression of the gene CXCL9 in their tumor-associated macrophages had far better clinical outcomes than those with higher expression of a gene named SPP1 by the immune cells.

https://www.miragenews.com/ludwig-lausanne-study-sheds-light-on-tumor-gene-1059776/

#miragenews